A controllable gene-expression system for the pathogenic fungus Candida glabrata
Open Access
- 1 September 1998
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 144 (9) , 2407-2415
- https://doi.org/10.1099/00221287-144-9-2407
Abstract
A system for controlling gene expression was established in the pathogenic fungus Candida glabrata to elucidate the physiological functions of genes. To control the expression of the gene of interest, the C. glabrata cells were first transformed with the plasmid carrying the tetracycline repressor-transactivator fusion tetR::GAL4, then with the DNA fragment containing the controllable cassette, the tetracycline operator chimeric promoter (tetO::ScHOP1). The peptide elongation factor 3 (CgTEF3) and DNA topoisomerase II (CgTOP2) genes from C. glabrata were cloned and their expression assessed using this system. When the promoter of CgTEF3 or CgTOP2 was replaced with tetO::ScHOP1, doxycycline almost completely repressed the expression of both mRNAs, and impaired growth. Repression of the TOP2 or TEF3 gene by doxycycline also hampered the survival of C. glabrata cells in mice; in mouse kidneys the number of C. glabrata cells, in which the TOP2 or TEF3 promoter was replaced with the tetO::ScHOP1 controllable cassette, did not increase when the mice were given doxycycline. Thus, it appears that the gene repression mediated by doxycycline occurred not only in culture media but also in animals; therefore, this system can be used to elucidate the function of the gene in fungal infections and pathogenesis.Keywords
This publication has 23 references indexed in Scilit:
- Fluconazole resistance in Candida glabrataAntimicrobial Agents and Chemotherapy, 1993
- Isolation and sequence analysis of the gene encoding translation elongation factor 3 from Candida albicansYeast, 1992
- Evolutionary relationships among pathogenic Candida species and relativesJournal of Bacteriology, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Topoisomerase II: A potential target for novel antifungal agentsBiochemical and Biophysical Research Communications, 1989
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985
- DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.Proceedings of the National Academy of Sciences, 1984
- Yeast DNA topoisomerase II is encoded by a single-copy, essential geneCell, 1984
- Disseminated Candida glabrata: Report of a Uniquely Severe Infection and a Literature ReviewAmerican Journal of Clinical Pathology, 1983
- Torulopsis glabrata infections in patients with cancerThe American Journal of Medicine, 1976